Related Experiment Video

Updated: May 28, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Overexpression of histidine-rich calcium binding protein in equine ventricular myocardium

R Sacchetto1, E Sharova, M Patruno

  • 1Department of Experimental Veterinary Sciences, University of Padova, 35020 Legnaro Padova, Italy. roberta.sacchetto@unipd.it

Veterinary Journal (London, England : 1997)
|November 2, 2011
PubMed

Insights

Histidine-rich calcium binding protein (HRC) is found in equine cardiac muscle, primarily in ventricles. This protein regulates calcium uptake and release, potentially impacting heart function in horses.

Area of Science:

  • Cardiovascular Biology
  • Muscle Physiology
  • Molecular Cardiology

Background:

  • Histidine-rich calcium binding protein (HRC) is a calcium-binding protein in mammalian striated muscles.
  • HRC interacts with sarcoplasmic reticulum (SR) membranes via triadin.
  • HRC's role in regulating SR calcium handling suggests involvement in heart failure and arrhythmias.

Purpose of the Study:

  • To investigate the expression and localization of HRC in equine cardiac muscle.
  • To compare HRC transcriptional activity between equine atria and ventricles.
  • To understand HRC's specific role in the unique physiology of the equine heart.

Main Methods:

  • Immunohistochemistry to detect HRC protein localization in SR membranes.
  • Quantitative real-time PCR to measure HRC mRNA levels in atrial and ventricular tissues.
  • Comparative analysis with cattle and donkey cardiac tissues.

Main Results:

  • Direct evidence of HRC protein expression associated with SR membranes in equine cardiac muscle was established.
  • HRC transcriptional activity was found to be approximately three times higher in equine ventricles compared to atria.
  • This ventricular predominance of HRC mRNA was specific to horses, unlike findings in cattle or donkeys.

Conclusions:

  • HRC is expressed in equine cardiac SR membranes, with significantly higher mRNA levels in ventricles.
  • This unique ventricular-specific upregulation of HRC in horses may be linked to their distinct cardiac electrophysiology.
  • Further research into HRC's function in equine hearts is warranted to understand its role in cardiac health and disease.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...